Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

PURPOSE: This study was designed to determine (1) rates of clinically meaningful tumor reduction in breast tumor size following neoadjuvant chemotherapy (NAC), (2) which receptor subtypes and MRI phenotypes are associated with clinically meaningful tumor reduction, and (3) whether MRI phenotype impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukhtar, Rita A., Yau, Christina, Rosen, Mark, Tandon, Vickram J., Hylton, Nola, Esserman, Laura J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824937/
https://www.ncbi.nlm.nih.gov/pubmed/23780381
http://dx.doi.org/10.1245/s10434-013-3038-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824937/
https://www.ncbi.nlm.nih.gov/pubmed/23780381
http://dx.doi.org/10.1245/s10434-013-3038-y

Ejemplares similares